Detalhe da pesquisa
1.
Pillars Article: Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation. Science. 1989. 246: 1617-1620.
J Immunol
; 201(11): 3149-3152, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455370
2.
Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.
Arthritis Rheum
; 65(11): 2791-802, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23897011
3.
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis.
Ann Rheum Dis
; 72(5): 776-80, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23434571
4.
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.
Ann Rheum Dis
; 70(6): 1153-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21444302
5.
Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis.
Arthritis Rheum
; 62(3): 694-704, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20131234
6.
Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood.
Arthritis Rheum
; 62(6): 1602-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20178127
7.
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.
Arthritis Rheum
; 62(12): 3607-14, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20722020
8.
B cell signature contributes to the prediction of RA development in patients with arthralgia.
Ann Rheum Dis
; 74(9): 1786-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26019192
9.
Loss of imprinting of IGF2 characterises high IGF2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis.
Ann Rheum Dis
; 69(6): 1239-42, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19556211
10.
A multi-parameter response prediction model for rituximab in rheumatoid arthritis.
Joint Bone Spine
; 85(2): 219-226, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28363827
11.
Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways.
Mol Cell Biol
; 22(2): 400-11, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11756537
12.
Gene expression profiling in rheumatology.
Methods Mol Med
; 136: 305-27, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17983157
13.
Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters.
Arthritis Res Ther
; 18(1): 290, 2016 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27955694
14.
The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes.
Arthritis Res Ther
; 18: 165, 2016 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27411379
15.
Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients.
Arthritis Res Ther
; 18(1): 205, 2016 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27629388
16.
Physiological evidence for diversification of IFNα- and IFNß-mediated response programs in different autoimmune diseases.
Arthritis Res Ther
; 18: 49, 2016 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26882897
17.
Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab.
Arthritis Res Ther
; 17: 78, 2015 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25889713
18.
Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation.
Cancer Immunol Res
; 3(5): 495-505, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25633713
19.
Oxidants and tyrosine phosphorylation: role of acute and chronic oxidative stress in T-and B-lymphocyte signaling.
Antioxid Redox Signal
; 4(3): 543-51, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12215222
20.
Moving towards personalized medicine in rheumatoid arthritis.
Arthritis Res Ther
; 16(3): 110, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25166016